Niagen Bioscience (NAGE) Return on Invested Capital (2016 - 2017)

Niagen Bioscience's (NAGE) quarterly Return on Invested Capital came in at 0.28% in Q3 2017, down 27.0% year-on-year from 0.39% in Q3 2016, and down 29.88% on a QoQ basis from 0.22% in Q3 2017.

Niagen Bioscience (NAGE) Return on Invested Capital (2016 - 2017) Analysis & Trends

Niagen Bioscience (NAGE) has 2 years of Return on Invested Capital data on file, last reported at 0.28% in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.04%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Niagen Bioscience 253.47 Mn 186.92 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 -0.28%
Jul 1, 2017 -0.22%
Apr 1, 2017 -0.14%
Oct 1, 2016 -0.01%
Jul 2, 2016 -0.01%
Apr 2, 2016 -0.01%